Skip to main content
Clinical Trials/ISRCTN40939838
ISRCTN40939838
Active, not recruiting
未知

Evaluation of specific unmet needs in the current clinical practice of multiple sclerosis: characterization of different profiles of relapsing multiple sclerosis patients defined by disease activity and patient-reported outcomes (Profile RMS)

Roche Pharma AG0 sites1,250 target enrollmentDecember 17, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Relapsing multiple sclerosis
Sponsor
Roche Pharma AG
Enrollment
1250
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2021
End Date
September 30, 2023
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. RRMS or rSPMS, diagnosed by revised McDonald 2010 criteria
  • 2\. Treatment naïve participants or participants without current treatment or participants being treated with an approved DMT according to the respective summary of product characteristics (SPC)

Exclusion Criteria

  • 1\. Participation in an interventional study or in NIS Confidence (ML39632\)
  • 2\. Participants not receiving treatment for MS with the studied DMTs according to the standard of care and in line with the current SPC
  • 3\. Off\-label use of any medication

Outcomes

Primary Outcomes

Not specified

Similar Trials